ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 725

Amniotic Membrane Dressings Provide an Effective Treatment for Systemic Sclerosis Digital Ulcers

Tracy Frech1, Jan Pierce 2, Greg Stoddard 3, Constance McNeill 4, Mislav Radic 5 and Jo -Anna Reems 6, 1Division of Rheumatology, University of Utah and Salt Lake VAMC, Salt Lake City, UT, 2University of Utah Regenerative Medicine, Salt Lake City, United Kingdom, 3University of Utah Study Design and Biostatics Core, Salt Lake City, UT, 4University of Utah Hospitals and Clinics, Salt Lake City, UT, 5University Hospital Split, Split, Croatia, 6University of Utah Regenerative Medicine, Salt Lake City, UT

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: nurse and clinical practice, Scleroderma, Systemic sclerosis, wounds

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic sclerosis (SSc)-related digital ulcers are a major burden for patients. The purpose of this study was to assess the effectiveness of amnion membrane treatments on healing rate as determined by manual and ultrasound weekly measurements.

Methods: SSc patients that met 2013 ACR/EULAR classification criteria and presented to clinic with a digital ulcer between 02/2019-05/2019 were consented to participate. Consented participants were asked to complete a Raynaud’s Condition Score (RCS), Hand Mobility in Scleroderma (HAMIS), Scleroderma Health Assessment Disability Questionnaire (HAQ-DI), and return every 5-7 days for a wound nurse’s visit until complete healing. All patients received education on wound care management including assessment, cleaning, and dressing. The volume of the wound was calculated and change in volume was tracked over time at the time of wound care.

Results: During the two-month study period, 15 SSc patients with a DU were approached for consent at the time of their routine SSc care visit. Two patients refused consent due to perceived burden of participation. Of the 13 consented patients, nine patients subsequently withdrew due to burden of participation; length questionnaires and driving to wound care were the most common reported reasons. Five patients had at least two formal measurements of their DU during wound care. Three patients did not return to wound care after the first follow-up visit due to complete healing reported. The demographics of the 5 SSc patients that returned for care included three female; four white patients; three limited cutaneous SSc, with a mean age of 62 (SD 11). The duration from first non-RP symptom of SSc was 5.8 years (SD 4). Wound volume (length x width x depth) ranged from 3 to 182 mm3. Two wounds (3 mm3 and 9 mm3) healed completely after one application and these patients did not return to wound care. One wound (39.2 mm3)  was over a joint contracture and traumatic in origin increased in volume at follow-up measurement.  The change in wound volume of these 5 wounds over time after amnion dressing was applied is shown in Figure 1. None of these SSc wound patients completed all questionnaires.

Conclusion: Assessments of SSc-related DU healing must minimize patient burden; the appropriate number of questionnaires used for assessment must be carefully assessed in the study design of this outcome, and remote wound monitoring should be considered. DU healing can be measured effectively by weekly ultrasound that estimates wound volume. Amnion membrane dressings are effective for wound healing in this patient population, especially for wounds that are vascular in origin.

Wound volume change with amniotic membrane dressing


Disclosure: T. Frech, None; J. Pierce, None; G. Stoddard, None; C. McNeill, None; M. Radic, None; J. Reems, None.

To cite this abstract in AMA style:

Frech T, Pierce J, Stoddard G, McNeill C, Radic M, Reems J. Amniotic Membrane Dressings Provide an Effective Treatment for Systemic Sclerosis Digital Ulcers [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/amniotic-membrane-dressings-provide-an-effective-treatment-for-systemic-sclerosis-digital-ulcers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/amniotic-membrane-dressings-provide-an-effective-treatment-for-systemic-sclerosis-digital-ulcers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology